Apella Capital, LLC Pfizer Inc Transaction History

Apella Capital, LLC

$2.41 Billion
Q3 2024

A detailed history of Apella Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Apella Capital, LLC holds 18,193 shares of PFE stock, worth $519,774. This represents 0.02% of its overall portfolio holdings.

Number of Shares

18,193

Previous 17,611 3.3%

Holding current value

$519,774

Previous $492,000 6.91%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$27.7 - $31.39 $16,121 - $18,268	582 Added 3.3%	18,193 $526,000
Q2 2024 Jul 10, 2024	BUY	$25.26 - $29.6 $72,193 - $84,596	2,858 Added 19.37%	17,611 $492,000
Q1 2024 Apr 10, 2024	SELL	$25.89 - $29.73 $11,935 - $13,705	-461 Reduced 3.03%	14,753 $409,000
Q4 2023 Jan 05, 2024	SELL	$26.13 - $33.94 $4,755 - $6,177	-182 Reduced 1.18%	15,214 $438,000
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $15,242 - $17,817	-475 Reduced 2.99%	15,396 $510,000
Q2 2023 Jul 06, 2023	SELL	$36.12 - $41.79 $74,443 - $86,129	-2,061 Reduced 11.49%	15,871 $582,000
Q4 2022 Jan 10, 2023	BUY	$41.75 - $54.5 $88,927 - $116,085	2,130 Added 13.48%	17,932 $0
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $23,761 - $29,007	543 Added 3.56%	15,802 $692,000
Q2 2022 Jul 08, 2022	BUY	$46.53 - $55.17 $49,042 - $58,149	1,054 Added 7.42%	15,259 $800,000
Q1 2022 Apr 11, 2022	BUY	$45.75 - $56.69 $6,039 - $7,483	132 Added 0.94%	14,205 $735,000
Q4 2021 Jan 13, 2022	BUY	$41.32 - $61.25 $19,007 - $28,175	460 Added 3.38%	14,073 $831,000
Q3 2021 Jan 18, 2022	SELL	$39.25 - $50.42 $9,498 - $12,201	-242 Reduced 1.75%	13,613 $585,000
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $9,930 - $12,756	253 Added 1.86%	13,855 $586,000
Q2 2021 Jan 18, 2022	SELL	$35.91 - $40.68 $6,894 - $7,810	-192 Reduced 1.39%	13,602 $533,000
Q2 2021 Jul 02, 2021	SELL	$35.91 - $40.68 $933 - $1,057	-26 Reduced 0.19%	13,794 $540,000
Q1 2021 Apr 15, 2021	SELL	$33.49 - $37.77 $2,846 - $3,210	-85 Reduced 0.61%	13,820 $501,000
Q4 2020 Feb 18, 2021	SELL	$33.47 - $42.56 $11,714 - $14,896	-350 Reduced 2.46%	13,905 $512,000
Q3 2020 Oct 22, 2020	BUY	$31.75 - $37.25 $15,081 - $17,693	475 Added 3.45%	14,255 $523,000
Q2 2020 Jul 20, 2020	BUY	$30.12 - $36.54 $212,858 - $258,228	7,067 Added 105.27%	13,780 $451,000
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $181,452 - $259,256	6,713 New	6,713 $219,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.

Account

Apella Capital, LLC Pfizer Inc Transaction History